Regarding the PAI-1 4G/5G polymorphism (Table 3), from the patients diagnosed with MetS, 66.7% of them had 4G/5G genotype, followed by 28.6% patients with 5G/5G polymorphism and 4.7% with 4G/4G form. The gene discussed is SERPINE1; the disease is metabolic syndrome.